Diabetes with coronary disease - A moving target amid evolving therapies?

New England Journal of Medicine

Volumn 360, Issue 24, 2009, Pages 2570-2572

  Boden, William E ^a   Taggart, David P ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BARE METAL STENT; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; EDITORIAL; GLYCEMIC CONTROL; HEART INFARCTION; HEART PROTECTION; HUMAN; LIFESTYLE MODIFICATION; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL RATE; TREATMENT OUTCOME; CARDIOVASCULAR DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANTIDIABETIC AGENT; INSULIN;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 67149136723     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0904090     Document Type: Editorial

References (13)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
2. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-225 [Erratum, N Engl J Med 1997;336:147.]
3. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-1606 (Pubitemid 46551631)
4. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009;373:1190-1197
5. The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-2515
6. American College of Cardiology National Cardiovascular Data Registry. Durham, NC: Duke Clinical Research Institute, 2009.
7. Babapulle MN, Joseph L, Bélisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004;364:583-591 (Pubitemid 39094175)
8. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-948 (Pubitemid 47393576)
9. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-1516 (Pubitemid 46588415)
10. Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-972
11. Taggart DP. PCI or CABG in coronary artery disease? Lancet 2009;373:1150-1152
12. Farkouh ME, Dangas G, Leon MB, et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J 2008;155:215-223
13. Simoons ML. Myocardial revascularization - bypass surgery or angioplasty? N Engl J Med 1996;335:275-277